-
Mashup Score: 10
A research team of the Korea Advanced Institute of Science and Technology (KAIST) has successfully developed a reversible treatment technology for colon cancer
Source: www.businesskorea.co.krCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 8Health Canada Approves Celltrion's Omricleo for Allergic Asthma and Chronic Urticaria - 27 day(s) ago
Celltrion’s treatment for allergic asthma and chronic idiopathic urticaria, Omricleo, has received product approval from Health Canada, marking a significant m
Source: www.businesskorea.co.krCategories: General Medicine News, Allergy-ImmunologyTweet-
Celltrion's treatment for allergic asthma and chronic idiopathic urticaria, Omricleo, has received product approval from Health Canada. Announced on Dec. 9, positions Omricleo as the first biosimilar of Xolair to be approved in Canada. https://t.co/nf4WTPoVDi https://t.co/eJQ6rZF4Jn
-
KAIST Develops Innovative Technology to Revert Colon Cancer Cells to Normal - Businesskorea https://t.co/HcYqtQZkzi